Abstract
The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have